---
category: news
title: "How is AI Progressing Drug Discovery?"
excerpt: "Artificial intelligence has been driven by advances in computational technology, resulting in an expanded ability to collect and process large volumes of data, which have been essential in drug discovery."
publishedDateTime: 2022-06-14T13:25:00Z
originalUrl: "https://www.azorobotics.com/Article.aspx?ArticleID=530"
webUrl: "https://www.azorobotics.com/Article.aspx?ArticleID=530"
type: article
quality: 19
heat: -1
published: false

provider:
  name: Azorobotics
  domain: azorobotics.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Ainnocence Launches Self-Evolving, Multi-Objective AI Drug Discovery Platform"
    excerpt: "Biotech and pharmaceutical companies looking to develop preclinical drug candidates can leverage Ainnocence's deep life-sciences knowledge and advanced computational techniques to accelerate the design of small-molecule,"
    publishedDateTime: 2022-06-13T10:00:00Z
    webUrl: "https://www.galvnews.com/news_ap/business/article_44fd210d-9596-5898-941a-382e7c96f802.html"
    type: article
    provider:
      name: Daily News
      domain: galvnews.com
    quality: 34
    images:
      - url: "https://bloximages.newyork1.vip.townnews.com/galvnews.com/content/tncms/custom/image/15a12480-fb7b-11ea-b7c4-87bc3f36b896.png?resize=600%2C338"
        width: 600
        height: 338
        isCached: true
  - title: "Ainnocence Applies AI To Drug Discovery"
    excerpt: "A new, San Diego-based biotech startup, Ainnocence launched today, saying that it is focused on using life-sciences knowledge and advanced computational techniques to accelerate the design of small-molecule,"
    publishedDateTime: 2022-06-13T13:22:00Z
    webUrl: "https://www.socaltech.com/ainnocence_applies_ai_to_drug_discovery/s-0082594.html"
    type: article
    provider:
      name: SocalTech
      domain: socaltech.com
    quality: 17

secured: "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;WMalfWgc9qwRE/sMIdbTlg=="
---

